M. Sc, CEO.
Andreas Gerward
Andreas has during the last 10 years worked with pharmaceutical development in smaller companies. Since joining Stayble as the CEO in 2014 Andreas has developed the company from selection of the candidate drug through preclinical development and successful clinical trials. Andreas has an engineering background and a master’s in economics and Venture Creation from Chalmers University of Technology.
andreas.gerward@stayble.se +46 (0)730 808 397Below is an overview of the Company’s largest owners as of 30 September 2024
| Name | Total shares | Percentage |
|---|---|---|
| Chalmers Ventures AB | 5 393 940 | 12.3% |
| Avanza Pension | 2 959 541 | 6.8% |
| ALMI Invest Västsverige AB | 1 935 584 | 4.4% |
| Handelsbanken Liv | 1 434 886 | 3.3% |
| Björn Sjöberg | 1 240 000 | 2.8% |
| Jacob Persson | 1 063 706 | 2.4% |
| Nordnet Pension | 976 457 | 2.2% |
| Magnus Kumbrant | 677 183 | 1.6% |
| Peter Olund | 642 001 | 1.5% |
| Futur Pension | 595 000 | 1.4% |
